Gil Milner
Director of Finance/CFO bei ROBOGROUP T.E.K. LTD.
Profil
Gil Milner is currently an Independent Director at Globe Energy Resources Y.C.D LP, a Director at Consus Ltd., and the Chief Financial Officer at RoboGroup T.E.K Ltd.
In the past, he worked as a Director at Anchiano Therapeutics Ltd., BioCancell Therapeutics, Inc., and Campus Bio Management Ltd.
He also served as the Chief Financial Officer & Comptroller at Clal Biotechnology Industries Ltd.
and as the Chief Financial Officer at Clal Biotechnology Industries Ltd.
(Venture Capital).
Mr. Milner received his undergraduate degree from Bar-Ilan University.
Aktive Positionen von Gil Milner
| Unternehmen | Position | Beginn |
|---|---|---|
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Director/Board Member | 18.06.2019 |
| ROBOGROUP T.E.K. LTD. | Director of Finance/CFO | - |
| Consus Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von Gil Milner
| Unternehmen | Position | Ende |
|---|---|---|
| ANCHIANO THERAPEUTICS LTD. | Director/Board Member | 01.07.2015 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Director/Board Member | - |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Director of Finance/CFO | - |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Director of Finance/CFO | - |
Ausbildung von Gil Milner
| Bar-Ilan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ROBOGROUP T.E.K. LTD. | Technology Services |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Energy Minerals |
| Private Unternehmen | 5 |
|---|---|
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Finance |
Campus Bio Management Ltd.
Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Consus Ltd. |
